Help us: Donate
Follow us on:
×

Menu

Back

Month: December 2020

Journal Club
Journal Club returns on January 26th at 12 pm Eastern / 5 pm UK with host Dr. Oliver Medvedik and special guests Drs. Irina and Michael Conboy. They recently demonstrated that a neutral blood exchange was able to spur rejuvenation in the brain and reduce inflammation. Additionally they compared this approach with a known senolytic...
Dr. Isabelle Schiffer at Ending Age-Related Diseases 2020
In this presentation given at Ending Age-Related Diseases 2020, Dr. Isabelle Schiffer of the Forever Healthy Foundation discusses the state of rejuvenation therapies and progress in bringing them into clinical practice. She discusses the rejuvenation market along with senotherapies, which target senescent cells in order to treat age-related diseases. This presentation featured the dasatinib +...
Dr. Ronjon Nag at Ending Age-Related Diseases 2020
In this presentation given at Ending Age-Related Diseases 2020, Dr. Ronjon Nag of the R42 Institute discusses his company's endeavors into biotechnology investment along with the nature of artificial intelligence and how it can be used to defeat aging. He discusses the myriad forms of artificial intelligence, including machine learning systems, and the achievements that...
Rejuvenation Roundup image for December 2020
Happy holidays from the Lifespan Extension Advocacy Foundation! While 2020 has been a trying year in many respects, rejuvenation research has continued throughout, and we are pleased to announce that we have plenty to discuss before we part for the holiday season. LEAF News We would like to remind you once again that on January...
Mouse brain maze
A new article published in Aging and Disease has taken a look at what two stem cell-activating growth factors can do in aged mice with Alzheimer's-like pathology. Alzheimer's disease (AD) is perhaps the most age-related of all age-related diseases. Perhaps not coincidentally, it has also been the most stubborn disease to develop treatments for. One...
Dr. Sajad Zalzala at Ending Age-Related Diseases 2020
In this presentation given at Ending Age-Related Diseases 2020, Dr. Sajad Zalzala of AgelessRx discusses PEARL, a human trial of rapamycin that uses the participation of ordinary people in order to get a large sample size without the expense of a traditional clinical trial. He discusses the use and effectiveness of rapamycin as an aging...